LCN2 and adrenal cortex carcinoma: The expression levels of the top anti-ACC core targets SLC3A2, BSG, SLC7A5, SLC7A6, LCN2, and SLC7A9 in ACC and normal samples were analyzed using the GEPIA2 database.